Immunology and cutaneous malignant melanoma.
D000328:Adult; D000912:Antibodies, Neoplasm; D001500:BCG Vaccine / Q000627:therapeutic use; D003601:Cytotoxicity Tests, Immunologic; D005260:Female; D006680:HLA Antigens; D006801:Humans; D007111:Immunity, Cellular; D007167:Immunotherapy / Q000009:adverse effects; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology; D008545:Melanoma / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D009362:Neoplasm Metastasis; D012878:Skin Neoplasms / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D012882:Skin Tests
D000912:Antibodies, Neoplasm; D001500:BCG Vaccine; D006680:HLA Antigens